Using an in vitro binding-site selection assay, we have demonstrated that c-Myc-Max complexes bind not only to canonical CACGTG or CATGTG motifs that are flanked by variable sequences but also to noncanonical sites that consist of an internal CG or TG dinucleotide in the context of particular variations in the CA--TG consensus. None of the selected sites contain an internal TA dinucleotide, suggesting that Myc proteins necessarily bind asymmetrically in the context of a CAT half-site. The noncanonical sites can all be bound by proteins of the Myc-Max family but not necessarily by the related CACGTG-and CATGTG-binding proteins USF and TFE3. Substitution of an arginine that is conserved in these proteins into MyoD (MyoD-R) changes its binding specificity so that it recognizes CACITG instead of the MyoD cognate sequence (CAGCTG).
R substitution changes the internal dinucleotide specificity of MyoD, it does not significantly alter its wild-type binding sequence preferences at positions outside of the CA--TG motif, suggesting that it does not dramatically change other important amino acid-DNA contacts; this observation has important implications for models of basic-helix-loop-helix protein-DNA binding.
Members of the Myc family of proteins (c-, N-, and L-Myc) have been implicated in oncogenesis, in progression through the cell cycle (39) , and in induction of apoptosis (25, 45) ; however, the direct targets of their activity remain unknown. Myc proteins are members (21) of the basic helix-loop-helix (bHLH) protein family (42) , in which the HLH domain is responsible for dimerization (42, 43) and the adjacent basic region mediates sequence-specific DNA binding (20, 56) . They belong to a bHLH protein subgroup (bHLH-LZ proteins) in which a leucine zipper motif (37) that is located immediately C terminal to the HLH domain seems to participate in the dimerization process (7, 26, 31, 40) . bHLH proteins bind DNA as dimers (20, 26, 42) to sequences that contain the palindromic consensus CA--TG (38) , with each respective basic region recognizing half of the site (14) . While Myc proteins can bind DNA in vitro as homodimers (1, 13, 35, 40) , they dimerize and bind DNA more efficiently with Max, a widely expressed bHLH-LZ protein (15, 48) that may play a critical role in their functions (2, 16, 34, 41, 47, 58) .
By analogy to other bHLH proteins (57) , it would be predicted that Myc complexes might be involved in transcriptional regulation (18, 39) , and recent evidence supports this idea (3, 33, 36) . However, very little is known about what genes they might regulate (10, 22, 39) . How their specificity of action is achieved is also unclear, since all Myc proteins can bind to the same CACGTG or CATGTG sequence (1, 11, 13, 34, 40, 46) . Moreover, a number of related bHLH proteins, including the bHLH-LZ transcriptional regulatory proteins USF, TFE3, and TFEB, also bind to these sites (8, 17, 29) , although some subtle differences among them have been identified (28, 30) .
To explore these issues, we have used the strategy of * Corresponding author.
sequential selection and amplification of binding sites (SAAB) (14) , in which binding sites are isolated in vitro from a pool of random-sequence oligonucleotides by a process of reiterative selection and polymerase chain reaction (PCR) amplification (14, 24, 51, 53) . We have selected a pool of c-Myc-Max binding sites, most of which contain the canonical CACGTG or CATGTG motif; however, to our surprise, others that bind strongly are noncanonical. All of the various types of noncanonical sites also share an internal CG or TG dinucleotide and can be bound specifically by Max and Myc family proteins but not necessarily by USF and TFE3. We have furthermore demonstrated that substitution of a single c-Myc basic region arginine (R) residue into the corresponding position in MyoD (20) changes its binding specificity so that it will now fail to recognize the MyoD preferred site (CAGCTG) and instead binds to canonical Myc family sites (CACGTG). However, like USF and TFE3, this MyoD mutant will bind to only a subset of the noncanonical sites. Thus, the ability to bind to an internal CG dinucleotide is not sufficient to allow binding to all of the noncanonical sequences, which appears to require specificity determinants that are shared by the Myc and Max proteins. An internal CG binding preference can be conferred upon MyoD without a dramatic alteration in its preferences at positions that flank the CA--TG consensus, suggesting that both the mutant and wild-type MyoD proteins make contact with DNA in an analogous fashion.
MATERIALS AND METHODS
Protein preparation. The IPmax preparation, which is a Max preparation that had been immunoprecipitated at low stringency from K562 cells, contains both the p21 and p22 forms of Max, thus representing binding by both (16) Max is phosphorylated by casein kinase II in mammalian cells (12, 16) and that this phosphorylation inhibits DNA binding by Max homodimers but not by c-Myc-Max heterodimers (12) . The c-, N-, and L-Myc-glutathione S-transferase fusion proteins and protocols for their preparation are described elsewhere (15, 40) . bHLH-LZ Max was produced by in vitro translation (in reticulocyte lysates; Promega) of RNA that encodes amino acids 13 to 96 of human Max preceded by the initiation methionine (32a) and was transcribed in vitro by standard procedures (14) . MyoD and its various mutants, which had been generated by oligonucleotide-directed mutagenesis (Amersham), were similarly produced by in vitro translation and quantitated as described previously (20) so that equivalent amounts could be used in each DNA-binding reaction.
DNA-binding and SAAB assays. DNA-binding reactions, including antibody supershifts, were performed essentially as described previously (16) except for omission of singlestranded DNA. Only reactions containing MyoD proteins were performed under different conditions (14) . IPmax reactions each contained 1.5 ,ul of protein (16) , reactions performed with bacterially expressed proteins contained about 250 ng of protein, and those performed with proteins that were produced by in vitro translation contained 5 or 10 ,ul of lysate each. Each reaction contained 5 x 10-10 M doublestranded DNA probe that had been labeled with 32P as described previously (14) . Oligonucleotide probes were labeled by kinase reactions, and then the opposite strand was annealed. Sites that were selected in vitro from randomsequence templates (see below) were labeled by PCR incorporation. In binding competition assays, unlabeled DNA was added to binding reactions immediately prior to addition of the labeled probe. Electrophoretic mobility shift assays (EMSAs) were performed on 5% polyacrylamide gels as described previously (14) .
The sequence of the CM1 probe has been described previously (13) . All oligonucleotide probes that were generated by annealing of complementary strands contain 5'-GATC-3' overhangs at both 5' ends. The sequences of their double-stranded portions are as follows: MD1, 5'-CCCCCA ACA9c1UTTGCCTGA-3'; CM3, 5'-CCCCCAACACGTG TTGCCTGA-3'; M2, 5'-ATCGCAACAGClC1lGT-lTATG-3'; M10, 5'-AAGGTAACAQXAiGGTTGTAGA-3'; and M45, 5'-TCAGCCAC(IJ3 CACAA-3'.
The various procedures and primers used in the SAAB assay have been described in detail previously (14) and were modified only in that selected DNA was eluted from polyacrylamide gels for 2 h to minimize elution of impurities that tended to generate PCR artifacts. Selections were performed by EMSA except for the first three rounds of the experiment shown in Fig. 6 , which were done by immunoprecipitation with an antiserum against MyoD. Double-stranded D6 and D9 templates were generated in Klenow reactions and isolated from preparative polyacrylamide gels (14) . The pool of amplified DNA that resulted from three rounds of selection for binding to IPmax (IPmaxD93) was digested with EcoRI and BamHI, which cut in the primer sequences, for subcloning into Bluescript plasmids. Single-stranded DNA (strand A) produced from individual clones was analyzed by dideoxy sequencing by the Sequenase method (U.S. Biochemical). Double-stranded DNA was then generated from these single-stranded DNA samples by PCR, using primers A and B, and labeled by PCR incorporation (14) for DNAbinding assays. The B strands of the clones analyzed in Fig.  3 were sequenced with 32P-labeled primer B as described previously (14) .
The pooled sequences shown in Fig. 7B were obtained by the same SAAB protocol but determined from a site pool that had been expanded to a size of 124 bp by PCR amplification with primers C (5'-TCGTAAGCTGACCTAG CATGCTACGCAATGCTGTAMACGGATCCATTGCA-3') and D (5'-CATCGACGCTCGTACACACTGTCCGTCTA GATGACTCCGAATTCCTACAG-3'), which overlap primers A and B in the underlined sequences. This PCR expansion was performed only on DNA that was used for sequencing and resulted in higher DNA yields and sequence data of generally better quality.
Methylation interference. Labeled DNA for methylation interference analysis was produced from individual selectedsite clones by PCR amplification (see above) in which primer A or B had been labeled with 32p in a kinase reaction. These templates were eluted from preparative polyacrylamide gels as described previously (14) . Methylation and cleavage reactions were performed as described elsewhere (38) . DNA-binding reactions were scaled up threefold, and the DNA and protein concentrations were doubled for these preparative EMSAs, in which less than half of the labeled material was present in the bound fraction. The bound and free DNA fractions were excised from dried-down EMSA gels and eluted as described previously (14) , and cleavage products were analyzed on 8% denaturing polyacrylamide gels as described elsewhere (38 (Fig. 1A) , in which 35 bp of random-sequence DNA are flanked by fixed sequences that permit PCR amplification and cloning. In the first selection round, the gel was run a short distance, and DNA was isolated by excision of the entire lane above the unbound template, making it possible to recover DNA that would be present in bound complexes that might not be readily detected (13) . In the second and third selection rounds, DNA was isolated from a single apparent protein-DNA complex (not shown) (Fig. 1B) . An antibody supershift analysis demonstrated that this complex contained both c-Myc and Max proteins (Fig. 1B) and thus that the isolated DNA represented a pool of c-Myc/Max binding sites.
Of 48 sites that were cloned and sequenced after the third selection round, 12 contained a CACGTG motif and 14 contained a CATGTG motif ( Fig. 2A) . The representation of CATGTG sites is probably artificially high because in five of these sites, half of this motif was contributed by fixed sequences that border the random sequences in D9 ( Fig. 1A  and 2A ). In a separate SAAB analysis, IPmax binding sites were isolated from an oligonucleotide template in which positions within and flanking a fixed CA--TG motif were random (not shown) (13) . In this latter experiment, both CACGTG and CATGTG sites were present after initial rounds, but with further selection, the CACGTG sites were present at an increasingly higher relative level and comprised most of the selected sites (not shown). These findings VOL. 13, 1993 (16) .
suggest that c-Myc-Max complexes can bind to CACGTG or CATGTG sites and that CACGTG sites constitute the greater proportion of their highest-affinity sites. None of the selected sites contained a symmetric CATATG motif ( Fig.  2A) , and no such sites were identified for IPmax in experiments in which a CAT motif had been fixed in the starting template (not shown), suggesting that c-Myc-Max complexes bind asymmetrically in the context of a CAT half-site. Presumably, c-Myc has a high affinity for one half-site in the hexamer and Max does for the other.
An alignment of the selected CACGTG and CATGTG sites suggested some sequence preferences at positions flanking these hexamers (Fig. 2B) . In both types of sites, these preferences were asymmetric, perhaps again deriving from a c-Myc preference on one half of the site and a Max preference on the other. However, with the exception of the A preference at -5 in both types of sites (Fig. 2B) , none of them corresponded to the 5'-GAC-3' flanking sequence in each half-site of a proposed 12-bp complete c-Myc binding site (30) . We also did not isolate any individual sites that had a GAC flanking sequence, although we isolated other flanking motifs (most frequently TAG) multiple times ( Fig. 2A ; not shown).
Twenty-two of the selected sequences did not include either a CACGTG or a CATGTG motif ( Fig. 2A) . None of them ( Fig. 2A and 3C ) corresponded to a proposed TCAT TCA site for cellular c-Myc-Max complexes (5, 44) , and under our conditions, neither IPmax nor bacterially expressed c-Myc-Max heterodimers bound to an oligonucleotide that contains this sequence (not shown). To distinguish sequences that might contain a noncanonical c-Myc-Max binding site from those that might have been isolated because of nonspecific binding, several were analyzed by EMSA for binding to IPmax (Fig. 2C ). Under these conditions, the overall affinity of binding by the selected pool (IPmaxD93) was severalfold greater than that of D9 (Fig.  2C) . Significantly, many of the individual selected sequences that did not contain a CA--TG hexamer bound to IPmax with affinities that are comparable to those of the CACGTG and CATGTG sites (Fig. 2C ).
We used a guanine methylation interference assay to map the site of c-Myc-Max binding within several of the highaffinity noncanonical sequences and to obtain an indication of some of the crucial DNA contacts ( Fig. 3A and B ; summarized in Fig. 3C ). Most of the alternative sites contained a noncanonical hexamer motif in which a CACGTG or CATGTG sequence had been substituted at position +2 with C or A (Fig. 3C) . The single exception, M45, appeared to be based on a CA--TG heptamer sequence (Fig. 3C) . Each of these motifs appeared in more than one selected sequence: CACGCG in M2 and M27; CACGAG in M10 and M42; CATGCG in M5, Mll, M18, and M36; and CACGTTG in M13 and M45 ( Fig. 2A) .
A striking feature of these interference patterns was the relative importance of interactions with G residues in the central 2 bp of each site (Fig. 3) . While the degree of interference at other G residues within these motifs varied, in every site examined, methylation of the internal G residues disrupted binding (Fig. 3) , a finding that is consistent with presence of a CG or TG dinucleotide in all of these types of IPmax sites and in all of the known bHLH-LZ protein binding sites (see above). Surprisingly, methylation of the G residue at +3 in M18 and in M36 did not appear to dramatically disrupt binding (Fig. 3) , even though this G residue defines part of the hexamer and is conserved in every site isolated ( Fig. 2A) . In contrast, methylation of the G residue at +4 in the heptameric sequence M45 does interfere, suggesting that this sequence may actually be read as a canonical CA--TG heptamer (Fig. 3) . Although binding interference was most striking within the consensus motifs, it was also apparent in flanking sequences in most of these sites. The conservation of flanking sequences between M2 and M10, and between M18 and M36, similarly suggests that these sequences may be important, as do the differences between the methylation interference patterns of M18 and M36.
Binding of bHLH-LZ proteins to selected c-Myc-Max sites. To more accurately assess the relative affinities with which IPmax binds to the noncanonical sites, three of them were assayed for binding in competition with CM1 (13, 15), a high-affinity CACGTG binding site for c-Myc and c-MycMax complexes (Fig. 4) . The M2 and M10 sequences competed about as well at a 100-fold molar excess as did unlabeled CM1 at a 25-fold excess, with M45 binding only slightly less strongly (Fig. 4, lanes 1 to 4 and 8 to 16 ). In contrast, a CAGCTG MyoD binding site (MD1) (14) competed only slightly better than did nonspecific DNA (Fig. 4 , lanes 5 to 7, and data not shown). The observation that these noncanonical sites bound to IPmax at affinities that were high but slightly lower than those of optimal CACGTG sites ( Fig. 2C and 4) is consistent with their relative levels of representation among the selected sequences ( Fig. 2A) .
Because all bHLH-LZ proteins examined so far bind to CACGTG (and CATGTG) sites, we have examined how well the noncanonical sites are bound by a panel of different bHLH-LZ proteins (for brevity, these results are presented in summary form in Fig. 3C ). Homodimers of a Max protein fragment that contains only the bHLH-LZ region bind with apparently equal affinity to each of the sites indicated in Fig.  3C (data not shown) position 8 and an arginine (R) at position 13 (15) (Fig. 5) . This R-13 residue is required for c-Myc binding to CACGTG sites (31) , its substitution into the bHLH protein AP4 allows binding to such a site (19) , and its substitution into MyoD allows heterodimers of this mutant with the bHLH protein E2A to bind to a CACGTG site (54) . The role of the conserved hydrophobic residue at 8 is unknown, but with a single exception (AP4 [32] ), bHLH proteins that lack R-13 have an R instead at position 8 (9) . We (14) .
the MD1 site (not shown). Substitution of L-8 and R-13 into
MyoD (MyoD-LR; Fig. 6A ) resulted in high-affinity binding to the CM3 site but not to MD1 (Fig. 6B, lanes 2 and 6) . A MyoD protein in which only R-13 was introduced (MyoD-R; Fig. 6A ) also did not bind to MD1 and bound well to CM3, although not quite as well as did MyoD-LR (Fig. 6B, lanes 4  and 8) . In contrast, MyoD-R bound at higher affinity to CATGTG sites than did either MyoD-LR or MyoD (not shown). The R-13 mutation thus appeared to allow MyoD to switch its specificity for the center 2 bp in the site from GC to CG (or TG), with the additional substitution of L-8 stabilizing interaction with the symmetric CACGTG site.
To test whether this change in specificity involves a difference in overall binding conformation, we used the SAAB technique to assay how such mutations affect the preferred binding sequences at positions within and flanking the CA--TG motif. We replaced the RERRRL sequence in MyoD with the c-Myc sequences LERQRR (MyoD-LQR; Fig. 6A ) and compared the binding preferences that MyoD and MyoD-LQR selected at positions within and flanking a fixed CA--TG consensus (Fig. 7B) . We assayed these preferences by sequencing the pool of selected sites, a procedure that yields a characteristic image, or imprint, of binding by a given protein (14) . After six selection rounds, the two respective proteins bound to their selected site pools with comparable affinities (Fig. 7A) . The MyoD binding-site preferences were identical to those previously determined between positions -5 and +5 (14) , most notably the A at -4, the central GC dinucleotide, and the T at +4, with additional preferences apparent at +6 and +7 (Fig. 7B) . MyoD-LQR instead preferred a central CG dinucleotide but was identical to MyoD in its preferences at -4 and +4 and very similar in (14), we have isolated sequences that are bound specifically by c-Myc-Max complexes that were isolated by low-stringency immunoprecipitation of Max from a mammalian cell line (16) . The predominant DNA-binding activity that we detect in this preparation consists of heteromeric c-Myc-Max complexes (Fig. 1) . Our most surprising result is that in addition to binding to the canonical CACGTG or CATGTG sites that were identified in previous studies (see above), these complexes bind to certain noncanonical DNA sequences ( Fig. 2A and 3C ). Preliminary results indicate that when linked to a basal promoter element, the noncanonical sequences that we have tested can mediate transcriptional activation by c-Myc and repression by Mad-Max heterodimers (not shown), as is characteristic of CACGTG sites (3, 6, 36) . The degree of activation and repression observed appears to vary among these sequences, and experiments are in progress to define the nature of these responses more precisely.
Of the canonical c-Myc-Max sites, the CACGTG sites are of generally higher affinity (Fig. 2 and data not shown) (1, 11, 13, 34) . Our data reveal only modest preferences in sequences that flank these canonical hexamers (Fig. 2B) . However, it is most interesting that these preferences are asymmetric, indicating perhaps that c-Myc and Max have different preferred half-sites, like MyoD and its bHLH dimerization partners, the E2A proteins (14) . The failure to observe certain bases at particular positions suggests that these bases might inhibit binding, as was first seen for E2A proteins (14) and more recently for c-Myc (30) and the yeast bHLH protein PH04 (28) . Our methylation interference results (Fig. 3) and those of other investigators (26) , further suggest that these flanking site positions are contacted by bHLH-LZ proteins. These findings are consistent with the idea that although flanking sequences can be important for binding by c-Myc-Max complexes, a large number of different sequence combinations will give high-affinity binding.
A striking observation from this analysis is the relative importance of the internal CG or TG dinucleotide. This sequence is present in every one of the canonical and noncanonical sites that we have identified ( Fig. 2A and 3C) , and its critical role is demonstrated by our methylation interference data (Fig. 3) , which show that it is in intimate contact with c-Myc-Max complexes and with MyoD-R. Similarly, although MyoD-LQR selects sequence preferences distal to the CA--TG motif (Fig. 7B) , during initial rounds of selection, these preferences were less dramatic than those for the central CG sequence (not shown). In contrast, by the same criteria, these flanking sequences are of greater importance for MyoD than is its central GC dinucleotide preference (not shown). Our results suggest that recognition of the internal CG (or TG) dinucleotide provides a substantial and critical contribution to the binding energy of these protein-DNA complexes.
These experiments also suggest that c-Myc-Max complexes and related proteins can recognize only particular combinations of their cognate half-sites. For example, although they can utilize a CAT half-site that is paired with GTG, binding to a symmetric CATATG sequence has not been observed (1, 40, 49 ) (data not shown). Thus, as is the case with E2A protein homodimers (14) , in these dimeric complexes, bHLH protein basic regions sometimes do not recognize their respective half-sites in a completely independent manner. In the noncanonical half-sites, only certain substitutions within the CA--TG motif seem to be allowed. For example, in the noncanonical hexamers ( Fig. 2A and  3C) , only A or C is substituted for T at position +2, and only one half-site is thus substituted in each site, indicating that the corresponding promoter (either c-Myc or Max, but not both simultaneously) can tolerate some degree of variation. It is not known whether other bHLH proteins will generally allow such substitutions in the CA--TG motif, but the Enhancer-of-split bHLH protein (which also contains the R-13 residue) appears to bind to a CACGAG site (52) . A variant form of the noncanonical sequences is represented by the apparent heptamers (M13 and M45; Fig. 2A and 3C ), a type of site that has also been isolated previously for the E2A proteins (50) . The methylation interference that we have observed at position +4 in M45 (Fig. 3) is consistent with the idea that they are true heptameric CA--TG sites, with a difference in spacing of the two basic regions allowing them to make analogous contacts with each half of the consensus.
Significantly, the different Myc family protein complexes that we have tested all bind specifically in vitro to the various types of canonical and noncanonical c-Myc-Max sites (Fig.  3C) , although some differences exist among them (for example, c-Myc homodimers are less likely to bind to CATGTG sites (13) (data not shown). In contrast, while USF, TFE3, and MyoD-R bind to the canonical sites, they are more restricted and do not bind to all of the noncanonical sites (Fig. 3C) . A substitution at position +2 in the CA--TG motif has the most dramatic effect on binding by bHLH-LZ proteins other than the Myc-Max family, with USF, TFE3, and MyoD-R not binding to the selected CATGCG sites (M18 and M36; Fig. 3C ). At position +3 in these two sites, the degree to which methylation interfered with c-Myc-Max binding was less than in other sites, suggesting that a difference in base-specific contacts may have been required for binding to them (Fig. 3C) . Our results indicate that presence of R-13 (and resulting preference of an internal CG or TG dinucleotide) is not sufficient to mediate recognition of all of the noncanonical sites. Max and its dimerization partners thus appear to share a determinant of binding specificity that allows them to bind to M18, M36, and M45; this determinant is lacking in the other R-13 bHLH proteins that we tested and could be identified by mutagenesis experiments.
General aspects of bHLH protein-DNA interactions. bHLH protein basic regions appear to adopt an a-helical conformation when binding to DNA (4, 27) , suggesting a structure analogous to that of LZ protein basic regions, which cross the major groove as at helices that make both base-specific and backbone-phosphate contacts (23) . When the basic region residues of bHLH proteins are thus arrayed, they display a "face" that would allow conserved amino acids access to the major groove (26, 27) , as would be consistent with methylation interference and mutational analyses (Fig.  3) (4, 26, 27 ). Two general types of helical models have been proposed for how bHLH proteins might bind to DNA. In one type, the R-13 residue within each basic region promoter would directly contact one of the CG (or TA) base pairs in the center of the site, and contacts with the remainder of the site would be maintained in an analogous fashion by all bHLH proteins (19, 31, 55) . In the other type of model, R-13 does not contact the central bases (27, 28) Fig. 6B ). This finding confirms and extends the conclusion of previous studies that the presence of this residue allows binding to CACGTG sites (19, 31, 54) . Significantly, we have furthermore shown that although MyoD-LQR preferentially binds to CACGTG sites, its preferred binding sequences at positions +4 and +5 remain almost identical to those of wild-type MyoD (Fig. 7B) . The most likely explanation for this latter result is that the LQR substitution has changed sequence recognition specifically at the central dinucleotide (from GC to CG) and that the basic regions of the R-13-substituted and wild-type MyoD molecules otherwise prefer to make analogous base-specific contacts over at least a 5-bp half-site. These findings suggest that the R-13 substitution does not cause the MyoD basic region to shift or ratchet along the major groove and instead are consistent with the idea that each R-13 residue instead contacts one of the central base pairs directly. The methylation interference patterns for binding of MyoD-R to the M2, M10, and M39 sites are virtually identical to those of c-Myc-Max (not shown), suggesting that these respective protein-DNA complexes also involve very similar basespecific interactions. Together, our findings suggest that all bHLH proteins make generally analogous contacts with the CA--TG consensus and flanking regions, but in the absence of sufficient structural information, such speculations and models should be interpreted with caution.
